# Long Term Therapy With Imatinib: Development of Late Side Effects and Compliance to Treatment

> **NCT00632255** · — · COMPLETED · sponsor: **Imperial College London** · enrollment: 88 (actual)

## Conditions studied

- Chronic Myeloid Leukemia
- Newly Diagnosed

## Interventions

- **DRUG:** Imatinib

## Key facts

- **NCT ID:** NCT00632255
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2019-07-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00632255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00632255, "Long Term Therapy With Imatinib: Development of Late Side Effects and Compliance to Treatment". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00632255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*